The Trust Deficit in AI-Assisted Radiology
Artificial intelligence models are increasingly embedded in radiology workflows, from detecting pulmonary nodules on chest CTs to flagging intracranial hemorrhages on head scans. These tools promise faster triage, reduced diagnostic error, and improved throughput. But for the radiologists, referring physicians, and patients who depend on their output, a critical question persists: why did the model reach that conclusion?
Most production-grade diagnostic AI models are deep neural networks — architecturally complex, statistically powerful, and fundamentally opaque. This opacity creates a trust deficit that is not merely philosophical. It has direct implications for patient safety, regulatory compliance, and organizational liability. For CISOs, compliance officers, and clinical informatics leaders, the challenge is to establish governance structures that make AI explainability a measurable, auditable property of every deployed model — not an afterthought.
Why Explainability Is a Security and Compliance Imperative
Explainability in AI is often framed as a clinical or ethical concern. It is equally a cybersecurity and regulatory one. The HIPAA Security Rule requires covered entities to implement policies and procedures for authorizing access to electronic protected health information (ePHI) and to maintain audit controls over information systems. When an AI model ingests thousands of DICOM images containing ePHI, processes them through opaque layers, and produces a diagnostic recommendation that influences clinical decisions, the organization must be able to demonstrate how that system behaves, under what conditions it fails, and what data it accessed and why.
The NIST AI Risk Management Framework (AI RMF 1.0), released in January 2023, explicitly identifies transparency and explainability as core characteristics of trustworthy AI. The framework's "Map" and "Measure" functions call on organizations to characterize AI risks in context, assess model behavior against defined criteria, and document decision-making processes. For healthcare organizations already aligned with the NIST Cybersecurity Framework (CSF), the AI RMF provides a natural extension — mapping AI-specific risks onto the familiar Identify, Protect, Detect, Respond, and Recover functions.
HITRUST CSF v11 has also incorporated AI-related control considerations, and organizations pursuing HITRUST certification should anticipate that third-party AI diagnostic tools will fall within the assessment boundary. The FDA's evolving guidance on Software as a Medical Device (SaMD), including its proposed framework for predetermined change control plans, further underscores the regulatory expectation that AI models in clinical use must be transparent, well-documented, and continuously monitored.
Practical Frameworks for Explainability Governance
1. Establish an AI Model Inventory and Risk Tiering
Before you can govern explainability, you need visibility. Apply the same asset management discipline required under CIS Control 1 (Inventory and Control of Enterprise Assets) to your AI portfolio. Catalog every AI/ML model deployed in clinical settings, including radiology. Document the model's vendor, training data provenance, FDA clearance status, integration points with EHR and PACS systems, and the type of clinical decision it influences. Use a risk-tiering methodology — the FAIR (Factor Analysis of Information Risk) model is well-suited here — to quantify the probable frequency and magnitude of loss events associated with model failure or adversarial manipulation.
2. Require Explainability Artifacts from Vendors
During procurement and vendor risk assessment, demand explainability documentation as a contractual deliverable. This should include model cards (as described by Google's Model Cards for Model Reporting), performance benchmarks disaggregated by patient demographics, saliency maps or attention visualizations for image-based models, and clear documentation of known failure modes. Integrate these requirements into your existing third-party risk management process aligned with NIST CSF PR.AT (Awareness and Training) and ID.SC (Supply Chain Risk Management).
3. Implement Continuous Monitoring and Drift Detection
An AI model that performed well during FDA review may degrade over time as patient populations shift, imaging hardware changes, or data pipelines introduce subtle artifacts. Establish continuous monitoring protocols — analogous to the NIST CSF DE.CM (Security Continuous Monitoring) function — that track model accuracy, calibration, and output distribution over time. Alert thresholds should trigger review by a cross-functional AI governance committee that includes radiology leadership, clinical informatics, information security, and compliance.
4. Create Clinician Feedback Loops
Explainability is not just about technical artifacts; it is about whether the radiologist at the workstation can understand, interrogate, and appropriately weigh the model's output. Implement structured feedback mechanisms that allow clinicians to flag cases where AI recommendations were clinically inappropriate, unexplainable, or misleading. This data becomes a critical input for model retraining, risk reassessment, and regulatory reporting. It also creates an auditable record demonstrating organizational diligence under HIPAA's administrative safeguard requirements.
Building a Culture of Trustworthy AI
Technology alone will not close the trust gap. Organizations must invest in clinician education about AI capabilities and limitations, establish clear accountability for AI-related adverse events, and foster a governance culture where questioning a model's output is encouraged rather than penalized. The CIS Controls emphasize security awareness (CIS Control 14), and this principle extends naturally to AI literacy. Radiologists should understand — at a conceptual level — how the models they rely on were trained, what explainability techniques (such as Grad-CAM, SHAP, or LIME) are being applied, and when to override algorithmic recommendations.
For CISOs and compliance officers, the strategic imperative is clear: explainable AI is not a feature request — it is a risk management requirement. Organizations that build robust explainability governance now will be better positioned to navigate the rapidly evolving regulatory landscape, protect patients, and earn the trust of the clinicians who must ultimately decide whether to act on an algorithm's recommendation.
The Bottom Line
Black-box AI in radiology introduces a category of risk that traditional cybersecurity and compliance frameworks were not originally designed to address. But the principles — asset visibility, risk quantification, continuous monitoring, vendor accountability, and workforce training — translate directly. By anchoring AI explainability in established frameworks like NIST CSF, NIST AI RMF, HITRUST, and FAIR, healthcare organizations can move from reactive concern to proactive governance, building the clinician trust that is essential for AI to deliver on its diagnostic promise safely and responsibly.